Glofitamab Antibody
Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody targeting CD20 on malignant B-cells, inducing T-cell-mediated cytotoxicity. It is utilized in research for relapsed/refractory B-cell lymphomas, with studies demonstrating its activity in both in vitro cytotoxicity assays and in vivo xenograft models.
Product Specifications
Product Name Alternative
CD20-TCB, RG 6026, RO7082859
Target
Others, Integrin, Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Concentration
2.85 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
170.37 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
349763-01 100 µg
CCND2, Recombinant, Human, aa1-289, His-Tag (Cyclin D2, G1/S-Specific Cyclin-D2)
Sign In for Pricing
View Details 349763-02 500 µg
CCND2, Recombinant, Human, aa1-289, His-Tag (Cyclin D2, G1/S-Specific Cyclin-D2)
Sign In for Pricing
View Details 